Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients
Abstract Background TIR domain containing adaptor molecule 1 (TICAM1) is a coding gene participating in immune and inflammation responses to malignant cells. However, the role of TICAM1 in Wilms tumor (WT) is rarely known. Materials and methods The expression level of TICAM1 was calculated in the WT...
Saved in:
Main Authors: | Zhiyi Lu (Author), Fengyin Sun (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of the expression patterns and potential prognostic role of m6A-RNA methylation regulators in Wilms Tumor
by: Changlin Jia, et al.
Published: (2023) -
CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor
by: Bin Xiang, et al.
Published: (2023) -
MicroRNA Profiling in Wilms Tumor: Identification of Potential Biomarkers
by: Fabiola Jimena Pérez-Linares, et al.
Published: (2020) -
Wilms Tumor
by: van den Heuvel-Eibrink
Published: (2016) -
Update on Wilms tumor
by: Klaudia Kister, et al.
Published: (2023)